Consolidated Statements of Stockholders' Equity - USD ($) |
Common Stock [Member] |
Additional Paid-in Capital [Member] |
Subscription Receivable [Member] |
Retained Earnings [Member] |
AOCI Attributable to Parent [Member] |
Noncontrolling Interest [Member] |
Total |
|||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at Sep. 30, 2023 | $ 74,925,851 | $ (73,371,987) | $ 120,493 | $ 1,674,357 | ||||||||
| Balance, shares at Sep. 30, 2023 | [1] | 37,432 | ||||||||||
| Common stock issued for cash | $ 1 | 1,897,112 | 1,897,113 | |||||||||
| Common Stock issued for cash, shares | [1] | 64,432 | ||||||||||
| Issued private placement | $ 1 | 4,499,998 | 4,499,999 | |||||||||
| Issued private placement, shares | [1] | 145,343 | ||||||||||
| Other comprehensive income | 312,906 | 312,906 | ||||||||||
| Net loss | (8,972,735) | (8,972,735) | ||||||||||
| Reversal of stock option expense | (62,308) | (62,308) | ||||||||||
| Treasury stock | ||||||||||||
| Treasury stock, shares | [1] | 1,705 | ||||||||||
| Balance at Sep. 30, 2024 | $ 2 | 81,260,653 | (82,344,722) | 433,399 | (650,668) | |||||||
| Balance, shares at Sep. 30, 2024 | [1],[2] | 248,912 | ||||||||||
| Common stock issued for cash | $ 1 | 1,382,843 | 1,382,844 | |||||||||
| Common Stock issued for cash, shares | [2] | 69,841 | ||||||||||
| Common stock compensation, shares | $ 0 | 523,680 | 523,680 | |||||||||
| Common stock compensation | [2] | 40,000 | ||||||||||
| Issued private placement | $ 2 | 1,999,998 | 2,000,000 | |||||||||
| Issued private placement, shares | [2] | 175,438 | ||||||||||
| Issued warrants | 1 | 1 | ||||||||||
| Issued warrants, shares | [2] | 2,799 | ||||||||||
| Other comprehensive income | (192,038) | (192,038) | ||||||||||
| Net loss | (1,536,249) | (1,536,249) | ||||||||||
| Balance at Dec. 31, 2024 | $ 5 | 85,167,175 | (83,880,971) | 241,361 | 1,527,570 | |||||||
| Balance, shares at Dec. 31, 2024 | [2] | 536,990 | ||||||||||
| Balance at Sep. 30, 2024 | $ 2 | 81,260,653 | (82,344,722) | 433,399 | (650,668) | |||||||
| Balance, shares at Sep. 30, 2024 | [1],[2] | 248,912 | ||||||||||
| Net loss | (1,921,805) | |||||||||||
| Balance at Mar. 31, 2025 | $ 15 | 95,167,165 | (438,701) | (84,266,527) | 178,844 | (19,374) | 10,621,422 | |||||
| Balance, shares at Mar. 31, 2025 | [2] | 1,509,871 | ||||||||||
| Balance at Sep. 30, 2024 | $ 2 | 81,260,653 | (82,344,722) | 433,399 | (650,668) | |||||||
| Balance, shares at Sep. 30, 2024 | [1],[2] | 248,912 | ||||||||||
| Common stock issued for cash | $ 15 | $ 13,382,015 | $ 13,382,030 | |||||||||
| Common Stock issued for cash, shares | 1,459,388 | [1] | 1,459,388 | |||||||||
| Common stock compensation, shares | [1] | $ 50,000 | ||||||||||
| Common stock compensation | 1 | 641,878 | 641,879 | |||||||||
| Issued private placement | $ 79 | $ 36,390,364 | $ 36,390,443 | |||||||||
| Issued private placement, shares | [1] | 7,880,438 | ||||||||||
| Issued warrants | ||||||||||||
| Issued warrants, shares | [1] | 2,799 | ||||||||||
| Other comprehensive income | (1,801) | (1,343) | (3,144) | |||||||||
| Net loss | (4,883,396) | (7,159) | (4,890,555) | |||||||||
| Acquisition of subsidiary | $ 2 | 856,743 | 803,719 | $ 1,660,464 | ||||||||
| Acquisition of subsidiary, shares | 184,167 | [1] | 184,167 | |||||||||
| Balance at Sep. 30, 2025 | $ 99 | 132,531,653 | (87,228,118) | 431,598 | 795,217 | $ 46,530,449 | ||||||
| Balance, shares at Sep. 30, 2025 | [1],[2] | 9,825,704 | ||||||||||
| Balance at Dec. 31, 2024 | $ 5 | 85,167,175 | (83,880,971) | 241,361 | 1,527,570 | |||||||
| Balance, shares at Dec. 31, 2024 | [2] | 536,990 | ||||||||||
| Common stock issued for cash | $ 10 | 9,999,990 | (438,701) | 9,561,299 | ||||||||
| Common Stock issued for cash, shares | [2] | 972,881 | ||||||||||
| Other comprehensive income | (62,517) | (62,517) | ||||||||||
| Net loss | (385,556) | (385,556) | ||||||||||
| Non-controlling interests | (19,374) | (19,374) | ||||||||||
| Balance at Mar. 31, 2025 | $ 15 | 95,167,165 | (438,701) | (84,266,527) | 178,844 | (19,374) | 10,621,422 | |||||
| Balance, shares at Mar. 31, 2025 | [2] | 1,509,871 | ||||||||||
| Balance at Sep. 30, 2025 | $ 99 | 132,531,653 | (87,228,118) | 431,598 | 795,217 | 46,530,449 | ||||||
| Balance, shares at Sep. 30, 2025 | [1],[2] | 9,825,704 | ||||||||||
| Common stock issued for cash | $ 4 | 1,999,996 | 2,000,000 | |||||||||
| Common Stock issued for cash, shares | [2] | 416,667 | ||||||||||
| Common stock compensation, shares | $ 4 | 1,163,972 | 1,163,976 | |||||||||
| Common stock compensation | [2] | 363,970 | ||||||||||
| Issued private placement | $ 36 | 16,177,464 | 16,177,500 | |||||||||
| Issued private placement, shares | [2] | 3,595,000 | ||||||||||
| Issued warrants | $ 13 | 10,088,603 | 10,088,616 | |||||||||
| Issued warrants, shares | [2] | 1,282,051 | ||||||||||
| Other comprehensive income | (15,522) | (1,566) | (17,088) | |||||||||
| Net loss | (19,443,692) | 17,419 | (19,426,273) | |||||||||
| Balance at Dec. 31, 2025 | $ 156 | 161,961,688 | (106,671,810) | 416,076 | 811,070 | 56,517,180 | ||||||
| Balance, shares at Dec. 31, 2025 | [2] | 15,483,392 | ||||||||||
| Balance at Sep. 30, 2025 | $ 99 | 132,531,653 | (87,228,118) | 431,598 | 795,217 | 46,530,449 | ||||||
| Balance, shares at Sep. 30, 2025 | [1],[2] | 9,825,704 | ||||||||||
| Net loss | (34,860,910) | |||||||||||
| Balance at Mar. 31, 2026 | $ 901 | 161,960,943 | (122,095,236) | 403,981 | 818,157 | 41,088,746 | ||||||
| Balance, shares at Mar. 31, 2026 | [2] | 89,971,288 | ||||||||||
| Balance at Dec. 31, 2025 | $ 156 | 161,961,688 | (106,671,810) | 416,076 | 811,070 | 56,517,180 | ||||||
| Balance, shares at Dec. 31, 2025 | [2] | 15,483,392 | ||||||||||
| Other comprehensive income | (13,181) | (1,825) | (15,006) | |||||||||
| Net loss | (15,423,426) | (11,211) | (15,434,637) | |||||||||
| Restricted stock award | $ 745 | (745) | ||||||||||
| Restricted stock award, shares | [2] | 74,487,896 | ||||||||||
| Disposal of subsidiary | 1,086 | 20,123 | 21,209 | |||||||||
| Balance at Mar. 31, 2026 | $ 901 | $ 161,960,943 | $ (122,095,236) | $ 403,981 | $ 818,157 | $ 41,088,746 | ||||||
| Balance, shares at Mar. 31, 2026 | [2] | 89,971,288 | ||||||||||
| ||||||||||||
| X | ||||||||||
- Definition Stock issued during period shares warrants. No definition available.
|
| X | ||||||||||
- Definition Stock issued during period value warrants. No definition available.
|
| X | ||||||||||
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of tax expense (benefit) allocated to other comprehensive income (loss) attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares issued which are neither cancelled nor held in the treasury. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of stock issued pursuant to acquisitions during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value of shares of stock issued attributable to transactions classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Aggregate value of stock related to Restricted Stock Awards issued during the period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of shares that have been repurchased during the period and are being held in treasury. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|